SCHEMBL8386243

SCHEMBL8386243

CS(=O)(=O)c1ccc(C2=C(c3ccccc3)CC3(CCCC3)C2)cn1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 18/20 0.51
PTGS1 P23219 9/20 0.45
RORC P51449 1/20 0.40
ALOX5AP P20292 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8384032 0.97 PTGS2 (0.51) PTGS2PTGS1RORCALOX5AP
SCHEMBL8384234 0.95 PTGS2 (0.50) PTGS2PTGS1RORC
SCHEMBL8386204 0.90 PTGS2 (0.58) PTGS2PTGS1ALOX5AP
SCHEMBL8385354 0.88 PTGS2 (0.67) PTGS2PTGS1
SCHEMBL8387434 0.88 PTGS2 (0.59) PTGS2PTGS1
SCHEMBL8383787 0.87 PTGS2 (0.58) PTGS2PTGS1ALOX5AP
SCHEMBL8384022 0.87 PTGS2 (0.48) PTGS2PTGS1
SCHEMBL8385142 0.86 PTGS2 (0.61) PTGS2PTGS1
SCHEMBL8383964 0.86 PTGS2 (0.48) PTGS2PTGS1ALOX5AP
SCHEMBL8384244 0.86 PTGS2 (0.67) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0743938-B1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 1999-04-21 EP claimed
EP-0743938-A1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-27 EP claimed
WO-1995021817-A1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-08-17 WO claimed
EP-0743938-B1 SUBSTITUTED SPIRO COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 1999-04-21 EP disclosed
US-5393790-A Diphenyl- or phenyl/pyridyl-substituted spiroheptenes, -octenes,-nonenes or -decenes; cyclooxygenase II inhibitors; side effect reduction; antipyretics; antiarthritic agents G.D. SEARLE & CO. (US) 1995-02-28 US disclosed